Status:
TERMINATED
A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas
Lead Sponsor:
Poitiers University Hospital
Conditions:
Leiomyoma
Eligibility:
FEMALE
25-49 years
Phase:
PHASE2
Brief Summary
The first indication of hysterectomies in France are uterine leiomyomas. When they are symptomatic leiomyomas are particularly responsables of an increase of menstruations duration and volume. Echogra...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients who are willing and able to participate in the study
- patients from whom written informed consent has been obtained
- patients who contribute to the National Insurance Scheme
- patients with an age between 25 and 49 years old
- non menopausal patients
- patients who use a non hormonal contraception
- patients with one or several , interstitial or subserous, uterine leiomyomas
- echographic diameter of leiomyomas must be equal or higher than 30 mm
- leiomyomas must be symptomatic
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00219778
Start Date
December 1 2004
End Date
February 1 2010
Last Update
April 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poitiers University Hospital
Poitiers, France, 86000